Table 3.
Clinicopathological features | No. of studies | No. of patients | Effects model | OR (95% CI) | P | Heterogeneity | |
---|---|---|---|---|---|---|---|
I 2 (%) | P h | ||||||
Gender (male vs female) | 6 | 1450 | Fixed | 1.38 (1.10-1.74) | .006 | 12.2 | .337 |
Tumor location (head vs body or tail) | 4 | 1106 | Fixed | 0.93 (0.72-1.20) | .582 | 16.8 | .307 |
Disease stage (metastasis vs locally advanced) | 2 | 828 | Random | 0.70 (0.17-2.90) | .623 | 93.7 | <.001 |
pN stage (N1 vs N0) | 2 | 278 | Random | 1.26 (0.42-3.77) | .675 | 64.7 | .093 |
Abbreviations: CAR, C-reactive protein to albumin ratio; OR, Odds ratio.